Bal Pharma Ltd Share Price (BALPHARMA)
as on
| Source : NSE
Bal Pharma Ltd Stock Performance
as on August 20, 2025 at 4:01 PM IST
Day's Low
Day's High
₹88₹92.7
1.03%
Downside
4.25%
Upside
52 Week's Low
52 Week's High
₹78.06₹157.9812.21%
Downside
77.67%
Upside
| Market Stats | |
| Previous Close | ₹91.08 |
| Open | ₹90.50 |
| Volume | 14.19K |
| Upper Circuit | ₹109.29 |
| Lower Circuit | ₹72.86 |
| Day's Low | ₹88 |
| Day's High | ₹92.7 |
| 52 Week Low | ₹78.06 |
| 52 Week High | ₹157.98 |
| Returns % | |
| 1 Month Return | -8.13 % |
| 3 Month Return | -7.67 % |
| 1 Year Return | -20.72 % |
| 3 Year Return | -4.83 % |
| 5 Year Return | + 87.79 % |
Bal Pharma Ltd Stock Fundamentals & Key Indicators
Check Bal Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹145.01 Cr
Return on Equity (ROE)
10.19
PE Ratio (TTM)
20.2
Return on capital employed (ROCE)
11.63
Industry PE ratio
43.53
Beta (LTM)
0.7
P/B Ratio
1.37
Dividend Yield
1.31
PEG Ratio
-37.4
Quarterly Earnings Growth YOY
-19.23
EPS (TTM)
4.71
Sector
Pharmaceuticals
Book Value
43.42
Technical Analysis
Bearish
View Technical Analysis
Bal Pharma Ltd Stock's Interest Amongst Investors
Bal Pharma Ltd Stock Valuation
Track how Bal Pharma Ltd P/E has moved over time to understand its valuation trends.
Bal Pharma Ltd in the last 5 years
Lowest (-535.88x)
June 15, 2018
Today (20.20x)
August 19, 2025
Industry (43.53x)
August 19, 2025
Highest (203.65x)
September 12, 2018
Today’s Price to Earnings Ratio: 20.20x
Bal Pharma Ltd Financial Results
Get the annual and quarterly financial summary of Bal Pharma Ltd, including revenue, profit, loss and more.
Bal Pharma Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Bal Pharma Ltd.
Bal Pharma Ltd Earnings Results
Bal Pharma Ltd’s net profit fell -19.23% since last year same period to ₹0.21Cr in the Q1 2025-2026. On a quarterly growth basis, Bal Pharma Ltd has generated -96.13% fall in its net profits since last 3-months.
Read More about Earnings ResultsBal Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Bal Pharma Ltd has declared dividend of ₹1.20 per share on 28 May 2024 - translating a dividend yield of 3.73%.
Read More about Dividends
Bal Pharma Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Bal Pharma Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.86% | 0.00 | |
| Foreign Institutions | 0.15% | 9.70 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 48.99% | ||
| Others | 0% | 0.00 |
Bal Pharma Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Bal Pharma Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 145.01 | 17.56% | 0.84 | 7 | 339 | |
| BUY | 8,013.96 | 10.61% | 0.72 | 3,597 | 4,565 | |
| NA | 45.19 | -16.85% | 0.00 | -22 | 104 | |
| NA | 714.35 | 63.1% | 0.58 | 13 | 154 | |
| NA | 46.99 | 19.79% | 0.50 | 1 | 67 |
Bal Pharma Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Bal Pharma Ltd.
Bal Pharma Reports Decline in Financial Performance - 10 Jun, 2025
Bal Pharma's standalone net sales for March 2025 fell 13.53% year-on-year to Rs 81.78 crore. Quarterly net profit decreased by 9.84% to Rs 5.61 crore, while EBITDA dropped 29.72%. The EPS also declined to Rs 3.51. The stock has seen negative returns of -17.97% over the last 6 months and -15.97% over the last 12 months.
Insights on Bal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 0.14% to 0.15% in Jun 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 50.86% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 28.7% return, outperforming this stock by 49.4%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.2% return, outperforming this stock by 144.0%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 82.96 Cr → 66.59 Cr (in ₹), with an average decrease of 19.7% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 49.00% to 48.99% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 5.43 Cr → 0.21 Cr (in ₹), with an average decrease of 96.1% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, BALPHARMA stock has moved down by -4.8%
About Bal Pharma Ltd
Revenue: ₹65.87Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.21Cr as on June 2025 (Q1 FY26)
Listing date: 08 May, 2006
| Organisation | Bal Pharma Ltd |
| Headquarters | Bangalore |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Bal Pharma Ltd share price today?
Bal Pharma Ltd share price today stands at ₹88.92, Open: ₹90.5, Previous Close: ₹91.08, High: ₹92.7, Low: ₹88, 52 Week High: ₹157.98, 52 Week Low: ₹78.06 as on .
How to buy Bal Pharma Ltd shares ?
To buy Bal Pharma Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for BALPHARMA or Bal Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Bal Pharma Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Bal Pharma Ltd?
Today's traded volume of Bal Pharma Ltd is 14.19K. Which means that 14.19K shares of Bal Pharma Ltd were bought and sold on the stock market during today's trading session.
What is Bal Pharma Ltd's market cap today?
Today's market capitalisation of Bal Pharma Ltd is ₹145.01 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Bal Pharma Ltd?
Bal Pharma Ltd’s 52 week high is ₹157.98 and 52 week low is ₹78.06. The current share price of Bal Pharma Ltd is ₹88.92, which is -43.71% down from its 52 week high and 13.91% up from its 52 week low.